HLA DRA Antibody (19-26.1 (same as MB-26.1))
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-45044
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Immunofluorescence, Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Monoclonal Mouse IgG2a Kappa Clone # 19-26.1 (same as MB-26.1)
Concentration
0.2 mg/ml
Product Summary for HLA DRA Antibody (19-26.1 (same as MB-26.1))
Immunogen
Raji cells
Localization
Cell surface
Specificity
This monoclonal antibody reacts with the HLA-DR antigen, a member of MHC class II molecules. It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36kDa alpha (heavy) chain and a 28kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. It is an excellent histiocytic marker in paraffin sections producing intense cytoplasmic staining. True histiocytic neoplasms are similarly positive. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2a Kappa
Description
200ug/ml of antibody purified from Bioreactor Concentrate by Protein A or G. Prepared in 10 mM PBS with 0.05% BSA & 0.05% azide. Also available WITHOUT BSA & azide at 1.0 mg/ml. (NBP3-11518)
Antibody with azide - store at 2 to 8C. Antibody without azide - store at -20 to -80C.
Antibody with azide - store at 2 to 8C. Antibody without azide - store at -20 to -80C.
Scientific Data Images for HLA DRA Antibody (19-26.1 (same as MB-26.1))
Immunohistochemistry-Paraffin: HLA DRA Antibody (19-26.1 (same as MB-26.1)) [NBP2-45044]
Immunohistochemistry-Paraffin: HLA DRA Antibody (19-26.1 (same as MB-26.1)) [NBP2-45044] - Human Tonsil stained with HLA-DRA Monoclonal Antibody (19-26.1).Flow Cytometry: HLA DRA Antibody (19-26.1 (same as MB-26.1)) [NBP2-45044]
Flow Cytometry: HLA DRA Antibody (19-26.1 (same as MB-26.1)) [NBP2-45044] - Flow Cytometric Analysis of Raji cells. HLA DRA Antibody (19-26.1 (same as MB-26.1)) followed by goat anti-Mouse IgG-CF488 (Blue); Isotype control (Red).Applications for HLA DRA Antibody (19-26.1 (same as MB-26.1))
Application
Recommended Usage
Flow Cytometry
1-2 ug/million cells
Immunocytochemistry/ Immunofluorescence
1-2 ug/ml
Immunofluorescence
0.5 - 1.0 ug/ml
Immunohistochemistry-Paraffin
1-2 ug/ml
Application Notes
Immunohistochemistry (Formalin-fixed): 1-2ug/ml for 30 minutes at RT. Staining of formalin-fixed tissues requires heating tissue sections in 10mM Tris with 1mM EDTA, pH 9.0, for 45 min at 95C followed by cooling at RT for 20 minutes.
Optimal dilution for a specific application should be determined.
Optimal dilution for a specific application should be determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
10 mM PBS with 0.05% BSA
Preservative
0.05% Sodium Azide
Concentration
0.2 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C.
Background: HLA DRA
Alternate Names
FLJ51114, histocompatibility antigen HLA-DR alpha, HLA class II histocompatibility antigen, DR alpha chain, HLA-DRA1, major histocompatibility complex, class II, DR alpha, MHC cell surface glycoprotein, MHC class II antigen DRA, MLRW
Gene Symbol
HLA-DRA
UniProt
Additional HLA DRA Products
Product Documents for HLA DRA Antibody (19-26.1 (same as MB-26.1))
Product Specific Notices for HLA DRA Antibody (19-26.1 (same as MB-26.1))
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...